A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study
暂无分享,去创建一个
J. Glenn | H. Wedemeyer | M. Kornberg | K. Deterding | K. Port | B. Bruno | A. Wranke | M. Manns | J. Kirschner | B. Martins